Home/Filings/4/0001127430-17-000017
4//SEC Filing

INSMED Inc 4

Accession 0001127430-17-000017

$INSMCIK 0001104506operating

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:17 PM ET

Size

16.2 KB

Accession

0001127430-17-000017

Insider Transaction Report

Form 4
Period: 2017-03-01
Drechsler Andrew T
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-03-01$6.65/sh+20,000$133,00025,000 total
  • Sale

    Common Stock

    2017-03-01$16.51/sh20,000$330,2005,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-03-0120,00074,855 total
    Exercise: $6.65Exp: 2022-11-07Common Stock (20,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-03-0110,00045,145 total
    Exercise: $6.65Exp: 2022-11-07Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2017-03-01$6.65/sh+10,000$66,50015,000 total
Footnotes (2)
  • [F1]The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.46 to $16.74, inclusive.
  • [F2]Stock options granted on November 7, 2012 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Issuer

INSMED Inc

CIK 0001104506

Entity typeoperating
IncorporatedVA

Related Parties

1
  • filerCIK 0001104506

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:17 PM ET
Size
16.2 KB